Kalani K - Search Results

1

QSAR guided semi-synthesis and in-vitro validation of anticancer activity in ursolic acid derivatives.

Kalani K, Yadav DK, Singh A, Khan F, Godbole MM, Srivastava SK. Kalani K, et al. Curr Top Med Chem. 2014;14(8):1005-13. doi: 10.2174/1568026614666140324121606. Curr Top Med Chem. 2014. PMID: 24660684

2

Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity.

Kalani K, Yadav DK, Khan F, Srivastava SK, Suri N. Kalani K, et al. J Mol Model. 2012 Jul;18(7):3389-413. doi: 10.1007/s00894-011-1327-6. Epub 2012 Jan 21. J Mol Model. 2012. PMID: 22271093

3

QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.

Yadav DK, Kalani K, Khan F, Srivastava SK. Yadav DK, et al. Among authors: kalani k. Med Chem. 2013 Dec;9(8):1073-84. doi: 10.2174/1573406411309080009. Med Chem. 2013. PMID: 23675978

4

Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7.

Yadav DK, Kalani K, Singh AK, Khan F, Srivastava SK, Pant AB. Yadav DK, et al. Among authors: kalani k. Curr Med Chem. 2014;21(9):1160-70. doi: 10.2174/09298673113206660330. Curr Med Chem. 2014. PMID: 24180274

5

QSAR and docking studies on capsazepine derivatives for immunomodulatory and anti-inflammatory activity.

Shukla A, Sharma P, Prakash O, Singh M, Kalani K, Khan F, Bawankule DU, Luqman S, Srivastava SK. Shukla A, et al. Among authors: kalani k. PLoS One. 2014 Jul 8;9(7):e100797. doi: 10.1371/journal.pone.0100797. eCollection 2014. PLoS One. 2014. PMID: 25003344 Free PMC article.

6

Anti-tubercular agents from Glycyrrhiza glabra.

Kalani K, Chaturvedi V, Alam S, Khan F, Srivastava SK. Kalani K, et al. Curr Top Med Chem. 2015;15(11):1043-9. doi: 10.2174/1568026615666150317223323. Curr Top Med Chem. 2015. PMID: 25786503

7

In-silico & In-vitro Identification of Structure-Activity Relationship Pattern of Serpentine & Gallic Acid Targeting PI3Kγ as Potential Anticancer Target.

Sharma P, Shukla A, Kalani K, Dubey V, Luqman S, Srivastava SK, Khan F. Sharma P, et al. Among authors: kalani k. Curr Cancer Drug Targets. 2017;17(8):722-734. doi: 10.2174/1568009617666170330152617. Curr Cancer Drug Targets. 2017. PMID: 28359246

8

In Vitro, In Silico and Ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents.

Kalani K, Alam S, Chaturvedi V, Singh S, Khan F, Srivastava SK. Kalani K, et al. Curr Top Med Chem. 2019;19(8):633-644. doi: 10.2174/1568026619666190305131425. Curr Top Med Chem. 2019. PMID: 30834834

9

In-silico Studies and Wet-Lab Validation of Camptothecin Derivatives for Anti-Cancer Activity Against Liver (HepG2) and Lung (A549) Cancer Cell Lines.

Kalani K, Yadav DK, Alam S, Khan F, Kashyap MP, Srivastava SK, Pant AB. Kalani K, et al. Curr Top Med Chem. 2021;21(10):908-919. doi: 10.2174/1568026621666210426124719. Curr Top Med Chem. 2021. PMID: 33902420

10

Cytotoxic evaluation of semisynthetic ester and amide derivatives of oleanolic acid.

Gupta S, Kalani K, Saxena M, Srivastava SK, Agrawal SK, Suri N, Saxena AK. Gupta S, et al. Among authors: kalani k. Nat Prod Commun. 2010 Oct;5(10):1567-70. Nat Prod Commun. 2010. PMID: 21121249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters